Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCC3153 | TNBC | Basal A | Mebendazole | 0.107 | uM | 13583.174 | 0.9377 | 0.6770 | 0.3654 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.533 | uM | 13583.174 | 0.7240 | -0.1737 | 0.3654 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 2.67 | uM | 13583.174 | 0.4908 | -0.7148 | 0.3654 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 13.3 | uM | 13583.174 | 0.6494 | -0.3865 | 0.3654 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 66.7 | uM | 13583.174 | 0.5117 | -0.6804 | 0.3654 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.000171 | uM | 13733.174 | 0.9553 | 0.8284 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.000853 | uM | 13733.174 | 0.9210 | 0.7015 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.00427 | uM | 13733.174 | 0.9449 | 0.7895 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.0213 | uM | 13733.174 | 0.9309 | 0.7377 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.107 | uM | 13733.174 | 0.9278 | 0.7262 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 0.533 | uM | 13733.174 | 0.8083 | 0.3168 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 2.67 | uM | 13733.174 | 0.7619 | 0.1725 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 13.3 | uM | 13733.174 | 0.7569 | 0.1574 | 0.5093 | |||
| HCC3153 | TNBC | Basal A | Mebendazole | 66.7 | uM | 13733.174 | 0.4901 | -0.5068 | 0.5093 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.000171 | uM | 12617.174 | 1.0039 | 1.0048 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.000853 | uM | 12617.174 | 0.9736 | 0.9667 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.00427 | uM | 12617.174 | 1.0100 | 1.0125 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.0213 | uM | 12617.174 | 0.9690 | 0.9609 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.107 | uM | 12617.174 | 0.9302 | 0.9113 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 0.533 | uM | 12617.174 | 0.4650 | 0.2369 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 2.67 | uM | 12617.174 | 0.3567 | 0.0474 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 13.3 | uM | 12617.174 | 0.2878 | -0.0846 | 1.5935 | |||
| HCC38 | TNBC | Basal B | Mebendazole | 66.7 | uM | 12617.174 | 0.1497 | -0.3927 | 1.5935 | |||
| HCC70 | TNBC | Basal A | Mebendazole | 0.000171 | uM | 12714.174 | 0.9520 | 0.7232 | 0.3306 | |||
| HCC70 | TNBC | Basal A | Mebendazole | 0.000853 | uM | 12714.174 | 0.9151 | 0.5293 | 0.3306 |